PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Overlooked peptide reveals clues to causes of Alzheimer's disease

Highly aggregative and neurotoxic amyloid peptide A-beta-43 points the way to new approaches for AD diagnosis and treatment

2011-07-04
(Press-News.org) Researchers at the RIKEN Brain Science Institute (BSI) and their collaborators have shed light on the function of a little-studied amyloid peptide in promoting Alzheimer's disease (AD). Their surprising findings reveal that the peptide is more abundant, more neurotoxic, and exhibits a higher propensity to aggregate than amyloidogenic agents studied in earlier research, suggesting a potential role in new approaches for preventing AD-causing amyloidosis.

An irreversible, progressive brain disease affecting millions worldwide, Alzheimer's disease is devastating for its victims, robbing them of their memory and cognitive skills and ultimately of their lives. Even after decades of research, however, the causes of AD remain elusive. Two features in the brain, abnormal clumps (senile plaques) and tangled bundles of fibers (neurofibrillary tangles), are known to characterize AD, but there is little consensus on the link between these features and the underlying roots of the disease.

One hypothesis that has attracted widespread support proposes that AD is caused by the buildup of the senile plaques, and in particular of their main constituent, amyloid-β peptides (Aβ). Two major forms of Aβ, Aβ40 and Aβ42, have been associated with genetic mutations causing early-onset AD, and have thus received considerable research attention. The role of longer Aβ species, in contrast, which also exist in the brains of Alzheimer's patients, has not yet been fully investigated.

In their current work, the researchers focused on Aβ43, an amyloid-β peptide found just as often in patient brains as Aβ42, but about which relatively little is known. To study the peptide's role in AD, they generated mice with a mutation causing overproduction of Aβ43, and used a highly sensitive system to distinguish between concentrations of Aβ40, Aβ42 and Aβ43.

Their surprising results reveal that Aβ43 is even more abundant in the brains of AD patients than Aβ40, and more neurotoxic than Aβ42. Aβ43 also exhibits the highest propensity to aggregate and considerably accelerates amyloid pathology. Moreover, unlike the other two Aβ species, which exist in human and mouse brains at birth, Aβ43 levels appear to increase with age, consistent with the pattern of AD onset.

Published in the journal Nature Neuroscience, the findings thus reveal the possible value of Aβ43 as a biomarker for diagnosis of AD and suggest a potential role in new approaches for preventing AD-causing amyloidosis, promising hope to AD sufferers around the world.

INFORMATION:

END



ELSE PRESS RELEASES FROM THIS DATE:

Warming ocean layers will undermine polar ice sheets

Warming ocean layers will undermine polar ice sheets
2011-07-04
Contact: Mari N. Jensen mnjensen@email.arizona.edu 520-626-9635 University of Arizona Daniel Stolte stolte@email.arizona.edu 520‑626‑4402 University of Arizona Warming ocean layers will undermine polar ice sheets Warming of the ocean's subsurface layers will melt underwater portions of the Greenland and Antarctic ice sheets faster than previously thought, according to new University of Arizona-led research. Such melting would increase the sea level more than already projected. The research, based on 19 state-of-the-art climate models, proposes ...

The Fraudulent Nature Of Psychiatric Labels.

2011-07-04
A new must-see video produced by the Citizens Commission on Human Rights International graphically demonstrates the fraudulent nature of all psychiatry's labels. The children in the video rip off their bogus psychiatric label and show a genuine label of their true nature. The name under the label of one child labeled with Attention Deficit Disorder (ADHD) is simply "Kid". 20 million children are now wearing these labels that are based solely on a checklist of behaviors. There are no brain scans, x-rays, genetic or blood tests that can prove the scientific ...

UBC 'megapixel' DNA replication technology promises faster, more precise diagnostics

2011-07-04
UBC researchers have developed a DNA measurement platform that sets dramatic new performance standards in the sensitivity and accuracy of sample screening. The advance could improve a range of genetic diagnostics and screenings where precise measurement is crucial--including the early detection of cancer, prenatal diagnostics, the detection of pathogens in food products, and the analysis of single cell gene expression. The new digital polymerase chain reaction (PCR) device uses liquid surface tension, rather than systems of microscopic valves, to partition DNA samples ...

Genetic variant linked to development of liver cancer in hepatitis C virus carriers

Genetic variant linked to development of liver cancer in hepatitis C virus carriers
2011-07-04
A genome-wide study by researchers at the RIKEN Center for Genomic Medicine, Hiroshima University Hospital and Sapporo-Kosei General Hospital has identified a genetic variant associated with the development of liver cancer in chronic hepatitis C virus carriers. The findings are based on a study of 3,312 Japanese individuals and appear in the journal Nature Genetics. Hepatocellular carcinoma (HCC), the most common type of liver cancer, is the third leading cancer-related cause of death and the seventh most common form of cancer worldwide. The hepatitis C virus (HVC) is ...

Logan Chierotti, Announces the Launch of his New Personal Website

2011-07-04
Logan Chierotti announces the launch of his new website. The new website gives details about Logan Chierotti and his passion for the outdoors and marketing. It elaborates on his experience with Internet marketing, business development and giving back to his community. The newly launched website gives information on Logan's previous business ventures and tells about his experience and passions. From the website users can access his blog which gives information on fly fishing, fitness and other passions that Logan has. The website was recently developed to give people ...

Could ovarian stimulation cause an increase in oocyte chromosome abnormalities?

2011-07-04
Stockholm, Sweden: Ovarian stimulation undertaken by women of advanced maternal age (over 35 years) receiving fertility treatment may be disrupting the normal pattern of meiosis – a critical process of chromosome duplication followed by two specialised cell divisions in the production of oocytes and sperm – and leading to abnormalities of chromosome copy numbers (aneuploidy) that result in IVF failure, pregnancy loss or, more rarely, the birth of affected children with conditions such as Down's syndrome, which is caused by the inheritance of three copies of chromosome 21 ...

Affordable London Holidays Easier with Low Cost Car Hire at Carrentals.co.uk

2011-07-04
A holiday in England's capital can be much more affordable by taking advantage of the low cost car hire rates offered from Carrentals.co.uk, one of the internet's leading rental rate comparators. They list the current prices from 50 of the world's top rental firms to over 15,000 popular travel destinations across the globe. London offers myriad things to do and experience, from strolls in Hyde Park to an evening theatre show in the West End. Famous restaurants are scattered all over the capital, as are iconic sites like Big Ben, the Tower of London and Buckingham Palace. ...

Biomarker MIA shows presence of neurofibromas

2011-07-04
Neurofibromatosis (NF1) is a genetic condition which affects one in every 3,000 people. The severity of symptoms can range from benign 'café au lait' patches on the skin, through small tumors under the skin and deep plexiform neurofibromas, to malignant tumors of the nerve sheath. New research published in BioMed Central's open access journal BMC Medicine shows that a simple blood test for the protein melanoma-inhibitory activity (MIA) could be used to indicate the presence of neurofibromas even if they cannot be seen. When researchers compared the levels of MIA from ...

Getting aid to where it is needed

2011-07-04
In the early 2000s, the international aid community started to fund health programs through Global Health Initiatives (GHIs) which provide aid and support for tackling infectious diseases, and for implementing immunization programs against childhood diseases. However priorities set by GHIs and by governments are not always the same. New research published in BioMed Central's open access journal Globalization and Health uses 'agency theory' to examine the conflicts between donor and recipient countries. In order to find out how GHIs have been operating, researchers from ...

"Speak like a President" Contest - Big Surprises Coming From The Participants

2011-07-04
As the celebration of Independence Day is drawing close, Audio4fun.com's Facebook video contest "Speak like a President" has received more and more submissions. To their staff's amazement, the first batch of submitted videos has proven that contestants' creativity is unlimited. The contest is open for submission until the end of July 10, 2011. To get more information about the contest, please visit http://www.audio4fun.com/contest2011.php. "It's impressive," said Tracy Nguyen, Brand Manager of Audio4fun.com and in charge of the contest, "the ...

LAST 30 PRESS RELEASES:

How rice plants tell head from toe during early growth

Scientists design solar-responsive biochar that accelerates environmental cleanup

Construction of a localized immune niche via supramolecular hydrogel vaccine to elicit durable and enhanced immunity against infectious diseases

Deep learning-based discovery of tetrahydrocarbazoles as broad-spectrum antitumor agents and click-activated strategy for targeted cancer therapy

DHL-11, a novel prieurianin-type limonoid isolated from Munronia henryi, targeting IMPDH2 to inhibit triple-negative breast cancer

Discovery of SARS-CoV-2 PLpro inhibitors and RIPK1 inhibitors with synergistic antiviral efficacy in a mouse COVID-19 model

Neg-entropy is the true drug target for chronic diseases

Oxygen-boosted dual-section microneedle patch for enhanced drug penetration and improved photodynamic and anti-inflammatory therapy in psoriasis

Early TB treatment reduced deaths from sepsis among people with HIV

Palmitoylation of Tfr1 enhances platelet ferroptosis and liver injury in heat stroke

Structure-guided design of picomolar-level macrocyclic TRPC5 channel inhibitors with antidepressant activity

Therapeutic drug monitoring of biologics in inflammatory bowel disease: An evidence-based multidisciplinary guidelines

New global review reveals integrating finance, technology, and governance is key to equitable climate action

New study reveals cyanobacteria may help spread antibiotic resistance in estuarine ecosystems

Around the world, children’s cooperative behaviors and norms converge toward community-specific norms in middle childhood, Boston College researchers report

How cultural norms shape childhood development

University of Phoenix research finds AI-integrated coursework strengthens student learning and career skills

Next generation genetics technology developed to counter the rise of antibiotic resistance

Ochsner Health hospitals named Best-in-State 2026

A new window into hemodialysis: How optical sensors could make treatment safer

High-dose therapy had lasting benefits for infants with stroke before or soon after birth

‘Energy efficiency’ key to mountain birds adapting to changing environmental conditions

Scientists now know why ovarian cancer spreads so rapidly in the abdomen

USF Health launches nation’s first fully integrated institute for voice, hearing and swallowing care and research

Why rethinking wellness could help students and teachers thrive

Seabirds ingest large quantities of pollutants, some of which have been banned for decades

When Earth’s magnetic field took its time flipping

Americans prefer to screen for cervical cancer in-clinic vs. at home

Rice lab to help develop bioprinted kidneys as part of ARPA-H PRINT program award

Researchers discover ABCA1 protein’s role in releasing molecular brakes on solid tumor immunotherapy

[Press-News.org] Overlooked peptide reveals clues to causes of Alzheimer's disease
Highly aggregative and neurotoxic amyloid peptide A-beta-43 points the way to new approaches for AD diagnosis and treatment